1 Min Read
Nov 29 (Reuters) - Biofrontera AG :
* European Commission provides unlimited approval for Ameluz Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.